Cell Cycle · 2009 · 50 citations · 18 references
MedicineMolecular BiologyOncologyBreast OncologyMolecular OncologyTumor ProgressionCancer Cell SignalingCancer ProgressionCell-cycle DysregulationCyclin-dependent KinasesMammary Epithelial Cell BiologyBreast Cancer PrognosisBreast Cancer ProgressionCancer-associated Cyclin-dependent KinasesCyclin E FamilyCyclin E OverexpressionCyclin E RegulationCyclin RegulationCyclins
Low molecular weight (LMW) isoforms of cyclin E are post-translationally generated in breast cancer cells and are associated with aggressive disease and poor prognosis. In this study, the specificity of LMW cyclin E to cancer cells was determined by measuring cyclin E expression in tumor and non-tumor tissue from 340 breast cancer patients. Our results reveal the LMW isoforms were detected significantly more frequently in breast tumor tissue than in adjacent non-tumor breast tissues (p < 0.0001). The biologic consequences of the LMW isoforms were studied using a non-tumorigenic mammary epithelial cell line transfected with the cyclin E isoforms and resulted in increased clonogenicity, the inability to enter quiescence in response to growth factor deprivation and genomic instability compared to the full-length cyclin E. Biochemical differences between the full-length and the LMW isoforms were also evident. Biacore analyses show that the LMW isoforms have more efficient binding to CDK2 compared to full-length cyclin E, which could account for the unique biologic consequences observed with the expression of LMW cyclin E. The LMW isoforms of cyclin E are tumor specific, and are biochemically and biologically distinct from the full-length cyclin E which could provide a novel role in breast cancer progression.
18
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Hiroaki Kiyokawa, Rhonda D. Kineman, Katia Manova‐Todorova et al. · Cell · 1996 · 1.3K citations · Full text
Cyclin E and Survival in Patients with Breast Cancer
Khandan Keyomarsi, Susan L. Tucker, Thomas A. Buchholz et al. · New England Journal of Medicine · 2002 · 557 citations · Full text
Medicine, Cell Biology, Oncology +15